ACADIA PHARMACEUTICALS INC Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2017 to Q3 2025
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2017 to Q3 2025.
- Acadia Pharmaceuticals Inc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2025 was 0.21 pure, unchanged year-over-year.
- Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2019 was 0.21 pure, unchanged from 2018.
- Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2018 was 0.21 pure, a 40% decline from 2017.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)